There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Shockwave Medical (SWAV – Research Report), Eledon Pharmaceuticals (ELDN – Research Report) and Evolent Health (EVH – Research Report) with bullish sentiments.
Shockwave Medical (SWAV)
Piper Sandler analyst Adam Maeder reiterated a Buy rating on Shockwave Medical today and set a price target of $315.00. The company’s shares closed last Monday at $202.17.
According to TipRanks.com, Maeder is a 5-star analyst with an average return of
Shockwave Medical has an analyst consensus of Moderate Buy, with a price target consensus of $266.90, a 33.7% upside from current levels. In a report issued on October 16, Leerink Partners also initiated coverage with a Buy rating on the stock with a $263.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Eledon Pharmaceuticals (ELDN)
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Eledon Pharmaceuticals, with a price target of $25.00. The company’s shares closed last Monday at $1.33, close to its 52-week low of $1.08.
According to TipRanks.com, Bernardino is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Eledon Pharmaceuticals with a $14.67 average price target.
Evolent Health (EVH)
In a report released today, Sean Dodge from RBC Capital maintained a Buy rating on Evolent Health, with a price target of $44.00. The company’s shares closed last Monday at $26.07.
According to TipRanks.com, Dodge is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Evolent Health with a $47.50 average price target, implying a 77.9% upside from current levels. In a report issued on October 16, UBS also initiated coverage with a Buy rating on the stock with a $46.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SWAV:
- Shockwave Medical Introduces Enhanced Coronary IVL Catheter in the United States
- ShockWave Medical introduces enhanced coronary IVL catheter in the U.S.
- ShockWave Medical announces two new publications on nodular, eccentric calcium
- New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies
- ShockWave Medical price target lowered to $250 from $316 at BofA
